Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
Paulzen
Michael
M
Orfanos
Stelios
S
Gründer
Gerhard
G
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000175:diagnosis*; D003024:Clozapine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008111:Liver Function Tests; D000068882:Paliperidone Palmitate; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012016:Reference Values; D018967:Risperidone / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*
D014150:Antipsychotic Agents; D007555:Isoxazoles; D011743:Pyrimidines; C058272:norclozapine; D003024:Clozapine; D018967:Risperidone; C079149:clozapine N-oxide; D000068882:Paliperidone Palmitate